ada.enesco, Author at European Medical Journal - Page 21 of 27

Majority of Iron Deficiency Cases Remain Unresolved After 3 Years

A recent study from a Minnesota statewide health system has revealed concerning data about the persistence of iron deficiency among patients.

Monoclonal Gammopathy of Undetermined Significance: Is Bone Marrow Sampling Needed?

A new multivariable model can predict smouldering multiple myeloma in patients with monoclonal gammopathy of undetermined significance, according to recent research.

Genomic Determinants of Relapse in Childhood Acute Lymphoblastic Leukaemia

A study has shed light on the genomic factors contributing to relapse in children with acute lymphoblastic leukaemia, the most common childhood tumour.

Study Uncovers Key Risk Factors for Monoclonal Gammopathy of Undetermined Significance

Research has identified several modifiable risk factors linked to monoclonal gammopathy of undetermined significance, by utilising advanced mass spectrometry techniques.

High-Risk Prostate Cancer Occasionally Mislabelled as Benign

A study shows that 8% of men with Gleason Grade Group 1 prostate cancer may have more aggressive disease. High PSA levels and extensive positive biopsy results are key risk factors.

AI Model Predicts Male Infertility Risk from Hormone Levels

A study has developed an AI model capable of predicting male infertility risk using hormone levels from a blood test.

Gut Microbiota May Predict Crohn’s Disease Recurrence Post-surgery

New research has shed light on the potential of the gut microbiota in predicting recurrence of Crohn’s disease following surgical remission.

Increased Aspiration Pneumonia Risk in GLP-1RA Users Undergoing Endoscopy

Use of glucagon-like peptide 1 receptor agonists is associated with an increased risk of aspiration pneumonia in patients undergoing gastrointestinal endoscopy, according to recent research.

Researchers Identify Biomarker for Recurrence in Renal Cell Carcinoma

A new study has developed and validated a 15-gene expression-based biomarker that could facilitate risk stratification for clear cell renal cell carcinoma.

Early-Stage Prostate Cancer May Be Missed in Transgender Women

Prostate-specific antigen screening may miss early-stage prostate cancer in transgender women undergoing oestrogen therapy, according to new research.